Owlet (OWLTW) Gains from Investment Securities (2020 - 2026)
Owlet (OWLTW) reported Gains from Investment Securities of -$61000.0 for Q1 2026, up 69.95% year-over-year from -$35892.8 in Q1 2025, and down 103.21% on a QoQ basis from $1.9 million in Q4 2025.
Owlet (OWLTW) has 7 years of Gains from Investment Securities data on file, last reported at -$61000.0 in Q1 2026.
- Quarterly Gains from Investment Securities rose 69.95% year-over-year to -$61000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (up 372.38% YoY) and the FY2025 annual result came in at $1.6 million, up 492.03% from the prior year.
- Gains from Investment Securities retreated to -$61000.0 in Q1 2026 per OWLTW's latest filing, from $1.9 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $1.9 million in Q4 2025 and bottomed at -$1.1 million in Q4 2024.
- The 5-year median for Gains from Investment Securities is -$35000.0 (2023), against an average of $96266.7.
- The widest annual swing landed in 2024, when Gains from Investment Securities jumped 2237.14%; it then slumped 754.84% in 2025.
- Tracing OWLTW's Gains from Investment Securities over 5 years: stood at $257000.0 in 2022, then soared by 83.27% to $471000.0 in 2023, then sank by 341.4% to -$1.1 million in 2024, then soared by 267.19% to $1.9 million in 2025, then slumped by 103.21% to -$61000.0 in 2026.
- Per Business Quant, the three latest OWLTW Gains from Investment Securities figures stand at -$61000.0 (Q1 2026), $1.9 million (Q4 2025), and -$57000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Owlet | - | - | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61,000.00 |
| Mar 31, 2026 | -61,000.00 |
| Dec 31, 2025 | 1.90 Mn |
| Dec 31, 2025 | 1.90 Mn |
| Sep 30, 2025 | -57,000.00 |
| Sep 30, 2025 | -57,000.00 |
| Jun 30, 2025 | -18,000.00 |
| Jun 30, 2025 | -18,000.00 |
| Mar 31, 2025 | -203,000.00 |
| Mar 31, 2025 | -203,000.00 |
| Dec 31, 2024 | -1.14 Mn |
| Dec 31, 2024 | -1.14 Mn |
| Sep 30, 2024 | 748,000.00 |
| Sep 30, 2024 | 748,000.00 |
| Jun 30, 2024 | -56,000.00 |
| Jun 30, 2024 | -56,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | 471,000.00 |
| Dec 31, 2023 | 471,000.00 |
| Sep 30, 2023 | -35,000.00 |
| Sep 30, 2023 | -35,000.00 |
| Jun 30, 2023 | 55,000.00 |
| Jun 30, 2023 | 55,000.00 |
| Mar 31, 2023 | -94,000.00 |
| Mar 31, 2023 | -94,000.00 |
| Dec 31, 2022 | 257,000.00 |
| Dec 31, 2022 | 257,000.00 |
| Mar 31, 2022 | -358,000.00 |
| Mar 31, 2022 | -358,000.00 |
| Dec 31, 2021 | 257,000.00 |
| Dec 31, 2021 | 257,000.00 |
| Jun 30, 2021 | 970,000.00 |
| Jun 30, 2021 | 970,000.00 |
| Mar 31, 2021 | 4.61 Mn |
| Mar 31, 2021 | 4.61 Mn |
| Dec 31, 2020 | 7.24 Mn |
| Dec 31, 2020 | 7.24 Mn |
| Sep 30, 2020 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |